Ramipril 10 mg Capsule in Healthy Subjects Under Fasting Conditions

Summary

The objective of this study is to compare the rate and extent of absorption of ramipril 10 mg capsule (test) versus Altace® (reference), administered as 1 x 10 mg capsule under fasting conditions.

Timeline

Start

2004-08

Primary completion

2004-10

Completion

2004-10

Outcome

Met primary endpoint

registry Ratio of the T/R geometric mean x 100 94.16 (90% CI 85.08 to 104.21) NCT00828321 ↗

registry Ratio of the T/R geometric mean x 100 102.22 (90% CI 96.21 to 108.6) NCT00828321 ↗

registry Ratio of the T/R geometric mean x 100 102.22 (90% CI 96.34 to 108.58) NCT00828321 ↗

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ramipril	Small molecule	10 mg	—

Indications

No indication recorded.